Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX3 | P56373 | 2/20 | 0.69 |
| ▸ | P2RX2 | Q9UBL9 | 2/20 | 0.69 |
| ▸ | DHFR | P00374 | 3/20 | 0.64 |
| ▸ | HTT | P42858 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | BLM | P54132 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ormetoprim SCHEMBL29389444 | 1.00 | P2RX3 (0.69) | P2RX3P2RX2DHFRHTTMEN1 | |
| SCHEMBL11555328 | 0.91 | P2RX3 (0.81) | P2RX3P2RX2DHFRHTTMEN1 | |
| SCHEMBL328871 | 0.88 | P2RX3 (0.72) | P2RX3P2RX2DHFRHTTMEN1 | |
| SCHEMBL1494157 | 0.85 | P2RX3 (0.73) | P2RX3P2RX2DHFRHTTMEN1 | |
| SCHEMBL30215873 | 0.85 | P2RX3 (0.73) | P2RX3P2RX2DHFRHTTMEN1 | |
| SCHEMBL2150300 | 0.84 | P2RX3 (0.67) | P2RX3P2RX2DHFRHTTMEN1 | |
| SCHEMBL2150191 | 0.83 | P2RX3 (0.70) | P2RX3P2RX2DHFRHTTMEN1 | |
| SCHEMBL11559756 | 0.82 | P2RX3 (0.65) | P2RX3P2RX2DHFRHTTMEN1 | |
| SCHEMBL1494010 | 0.82 | P2RX3 (1.00) | P2RX3P2RX2DHFRHTTMEN1 | |
| SCHEMBL29384647 | 0.82 | P2RX3 (1.00) | P2RX3P2RX2DHFRHTTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1713 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230193225-A1 | NEW USES OF A MUTATED LACTONASE, AND COMPOSITIONS | AIX-MARSEILLE UNIVERSITE (FR) | 2023-06-22 | — | — | US | claimed |
| CN-112034054-B | Method for detecting content of olmeprin in aquatic product | 厦门鉴科检测技术有限公司 | 2022-09-02 | — | — | CN | claimed |
| WO-2022046930-A1 | ANTIVIRAL AND ANTIMICROBIAL PROTECTIVE FILMS WITH MICROSTRUCTURE DETERRENTS | LUMENCO, LLC (US) | 2022-03-03 | — | — | WO | claimed |
| US-20220063178-A1 | ANTIVIRAL AND ANTIMICROBIAL PROTECTIVE FILMS WITH MICROSTRUCTURE DETERRENTS COMBINED WITH THERMALLY ELASTOMERIC AND EMBEDDED CHEMICAL ANTI-BACTERIAL OR ANTI-VIRAL AGENTS | MICROBEPROOF, LLC | 2022-03-03 | — | — | US | claimed |
| US-20220048979-A1 | TREATMENT OF STAPHYLOCOCCAL DISORDERS | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERAN AFFAIRS | 2022-02-17 | — | — | US | claimed |
| EP-3941206-A1 | NEW USES OF A MUTATED LACTONASE, AND COMPOSITIONS | Fondation Méditerranée Infection (FR) | 2022-01-26 | — | — | EP | claimed |
| CN-112034054-A | Method for detecting content of olmeprin in aquatic product | 厦门鉴科检测技术有限公司 | 2020-12-04 | — | — | CN | claimed |
| WO-2020187861-A1 | NEW USES OF A MUTATED LACTONASE, AND COMPOSITIONS | FONDATION MEDITERRANEE INFECTION (FR) | 2020-09-24 | — | — | WO | claimed |
| EP-2953624-B1 | METHODS OF TREATING MICROBIAL INFECTIONS, INCLUDING MASTITIS | LUODA PHARMA LTD (IE) | 2019-08-21 | — | — | EP | claimed |
| CN-109432106-A | A kind of compound sulfonamide chlorine pyridazine and preparation method thereof | 镇江威特药业有限责任公司 | 2019-03-08 | — | — | CN | claimed |
| CN-1441790-A | Enhanced propertied pharmaceuticals | ROHM & HAAS (US) | 2003-09-10 | — | — | CN | claimed |
| EP-1272463-A1 | ENHANCED PROPERTIED PHARMACEUTICALS | ROHM AND HAAS COMPANY (US) | 2003-01-08 | — | — | EP | claimed |
| WO-2001054481-A2 | ENHANCED PROPERTIED PHARMACEUTICALS | ROHM AND HAAS COMPANY (US) | 2001-08-02 | — | — | WO | claimed |
| US-6211185-B1 | ADMINISTERING ORALLY WITH DRINKING WATER | VETERINARY PHARMACY CORPORATION | 2001-04-03 | — | — | US | claimed |
| US-5258373-A | SYNERGISTIC MIXTURE OF SULFADIMETHOXINE, ORMETOPRIM AND FRENOLICIN-B | HOFFMANN-LA ROCHE INC. (US) | 1993-11-02 | — | — | US | claimed |
| EP-0523529-A2 | Anticoccidial compositions | F. HOFFMANN-LA ROCHE AG (CH) | 1993-01-20 | — | — | EP | claimed |
| US-5135924-A | For non-humans; canines, bovines, equines; treating systemic bacterial infections | HOFFMANN-LA ROCHE INC. (US) | 1992-08-04 | — | — | US | claimed |
| US-5063219-A | Anticoccidial composition | HOFFMANN-LA ROCHE INC. (US) | 1991-11-05 | — | — | US | claimed |
| US-4996198-A | Mixture of 2,4-diamino-5-(trisubstituted)benzyl-pyrimidine potentiated sulfonamide antibiotic with an ionophorous polyether | HOFFMANN-LA ROCHE INC. (US) | 1991-02-26 | — | — | US | claimed |
| US-4599416-A | Process for the preparation of aqueous solutions of potentiated sulfonamides | HOFFMANN-LA ROCHE INC. (US) | 1986-07-08 | — | — | US | claimed |